Lung Cancer Therapeutics Market
Lung Cancer Therapeutics Market - Global Industry Assessment & Forecast
#
Pages:
210
Base Year:
2023
Sep - 2024
Format:
Report Code:
VMR-2568
Segments Covered
By
Therapy Radiation Therapy, Targeted Therapy, Immunotherapy, Chemotherapy, Others
-
By
Lung Cancer Type Small Cell Lung Cancer, Non-small Cell Lung Cancer, Lung Carcinoid Tumor
-
By
Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
-
By
Type of Molecule Small molecules, Biologics
-
By
Drug Class Alkylating Agents, Antimetabolites, EGFR Inhibitors, Mitotic Inhibitors, Multikinase Inhibitors, Others
-
By
Region North America , Europe , Asia Pacific , Latin America , The Middle-East and Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 29.1 Billion |
 Revenue 2032:
|
USD 63.7 Billion |
 Revenue CAGR
(2024 - 2032): |
9.1 % |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Lung Cancer Therapeutics Market Segment Analysis
- Lung Cancer Therapeutics Therapy Outlook (Revenue, USD Million, 2018 - 2030)
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Lung Cancer Therapeutics Lung Cancer Type Outlook (Revenue, USD Million, 2018 - 2030)
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Lung Cancer Therapeutics Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Lung Cancer Therapeutics Type of Molecule Outlook (Revenue, USD Million, 2018 - 2030)
- Small molecules
- Biologics
- Lung Cancer Therapeutics Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
-
North America Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
-
North America Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
North America Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
-
North America Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- U.S.
- U.S. Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- U.S. Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- U.S. Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U.S. Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- U.S. Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- U.S. Lung Cancer Therapeutics Market, by Therapy
- Canada
- Canada Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Canada Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Canada Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Canada Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Canada Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Canada Lung Cancer Therapeutics Market, by Therapy
-
Mexico
- Mexico Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Mexico Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Mexico Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Mexico Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Mexico Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Mexico Lung Cancer Therapeutics Market, by Therapy
-
North America Lung Cancer Therapeutics Market, by Therapy
- Europe
-
Europe Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
-
Europe Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
-
Europe Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
Europe Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
-
Europe Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- U. K.
- U.K. Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- U.K. Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- U.K. Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U.K. Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- U.K. Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- U.K. Lung Cancer Therapeutics Market, by Therapy
- France
- France Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- France Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- France Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- France Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- France Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- France Lung Cancer Therapeutics Market, by Therapy
-
Germany
- Germany Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Germany Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Germany Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Germany Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Germany Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Germany Lung Cancer Therapeutics Market, by Therapy
-
Italy
- Italy Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Italy Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Italy Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Italy Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Italy Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Italy Lung Cancer Therapeutics Market, by Therapy
-
Spain
- Spain Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Spain Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Spain Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Spain Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Spain Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Spain Lung Cancer Therapeutics Market, by Therapy
-
Rest of Europe
- Rest of Europe Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Rest of Europe Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Rest of Europe Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Europe Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Rest of Europe Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Rest of Europe Lung Cancer Therapeutics Market, by Therapy
-
Europe Lung Cancer Therapeutics Market, by Therapy
- Asia Pacific
-
Asia Pacific Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
-
Asia Pacific Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
-
Asia Pacific Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
Asia Pacific Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
-
Asia Pacific Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- China
- China Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- China Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- China Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- China Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- China Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- China Lung Cancer Therapeutics Market, by Therapy
- Japan
- Japan Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Japan Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Japan Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Japan Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Japan Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Japan Lung Cancer Therapeutics Market, by Therapy
-
Germany
- Germany Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Germany Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Germany Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Germany Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Germany Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Germany Lung Cancer Therapeutics Market, by Therapy
-
India
- India Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- India Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- India Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- India Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- India Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- India Lung Cancer Therapeutics Market, by Therapy
-
South Korea
- South Korea Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- South Korea Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- South Korea Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- South Korea Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- South Korea Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- South Korea Lung Cancer Therapeutics Market, by Therapy
-
South East Asia
- South East Asia Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- South East Asia Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- South East Asia Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- South East Asia Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- South East Asia Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- South East Asia Lung Cancer Therapeutics Market, by Therapy
-
Rest of Asia Pacific
- Rest of Asia Pacific Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Rest of Asia Pacific Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Rest of Asia Pacific Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Asia Pacific Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Rest of Asia Pacific Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Rest of Asia Pacific Lung Cancer Therapeutics Market, by Therapy
-
Asia Pacific Lung Cancer Therapeutics Market, by Therapy
- Latin America
-
Latin America Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
-
Latin America Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
-
Latin America Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
Latin America Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
-
Latin America Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Brazil
- Brazil Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Brazil Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Brazil Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Brazil Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Brazil Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Brazil Lung Cancer Therapeutics Market, by Therapy
- Argentina
- Argentina Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Argentina Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Argentina Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Argentina Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Argentina Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Argentina Lung Cancer Therapeutics Market, by Therapy
-
Rest of Latin America
- Rest of Latin America Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Rest of Latin America Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Rest of Latin America Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Latin America Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Rest of Latin America Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Rest of Latin America Lung Cancer Therapeutics Market, by Therapy
-
Latin America Lung Cancer Therapeutics Market, by Therapy
- Middle East & Africa
-
Middle East & Africa Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
-
Middle East & Africa Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
-
Middle East & Africa Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
Middle East & Africa Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
-
Middle East & Africa Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- GCC Countries
- GCC Countries Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- GCC Countries Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- GCC Countries Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- GCC Countries Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- GCC Countries Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- GCC Countries Lung Cancer Therapeutics Market, by Therapy
- South Africa
- South Africa Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- South Africa Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- South Africa Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- South Africa Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- South Africa Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- South Africa Lung Cancer Therapeutics Market, by Therapy
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Lung Cancer Therapeutics Market, by Therapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Rest of Middle East & Africa Lung Cancer Therapeutics Market, by Lung Cancer Type
- Small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Lung Carcinoid Tumor
- Rest of Middle East & Africa Lung Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Middle East & Africa Lung Cancer Therapeutics Market, by Type of Molecule
- Small molecules
- Biologics
- Rest of Middle East & Africa Lung Cancer Therapeutics Market, by Drug Class
- Alkylating Agents
- Antimetabolites
- EGFR Inhibitors
- Mitotic Inhibitors
- Multikinase Inhibitors
- Others
- Rest of Middle East & Africa Lung Cancer Therapeutics Market, by Therapy
-
Middle East & Africa Lung Cancer Therapeutics Market, by Therapy
- North America
FAQ
Frequently Asked Question
What is the global demand for Lung Cancer Therapeutics in terms of revenue?
-
The global Lung Cancer Therapeutics valued at USD 29.1 Billion in 2023 and is expected to reach USD 63.7 Billion in 2032 growing at a CAGR of 9.1 %.
Which are the prominent players in the market?
-
The prominent players in the market are AstraZeneca PLC (UK), Boehringer Ingelheim International GmbH (Germany), Bristol Myers Squibb Company (U.S.), Eli Lilly and Company (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Allergan Inc. (Ireland), Teva Pharmaceutical Industries Ltd. (Israel), Abbvie Inc. (U.S.), Johnson & Johnson (U.S.), Amgen Inc. (U.S.), Novartis AG (Switzerland).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 9.1 % between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Lung Cancer Therapeutics include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Lung Cancer Therapeutics in 2023.
